In this week's of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.

The GameChanger
Marijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Marry Vuong, PharmD, BCPPS
Clinical Pharmacy Manager
Perfecting Peds

Reference
UPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business Times

NPR: Scientists welcome new rules on marijuana, but research will still face obstacles.

CEimpact Course for Reference:
Beyond the Haze: Pharmacist's Legal Insights on THC, CBD, and Medical Marijuana

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the reclassification of marijuana from Schedule I to Schedule III.
2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-180-H01-P
Initial release date: 05/27/2024
Expiration date: 05/27/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Join us as we discuss new guidelines from the American College of Gastroenterology for the management of acute pancreatitis.
The GameChanger
New guidelines from the ACG address changes in treatment and management of acute pancreatitis.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
The American Journal of Gastroenterology
Drug-Induced Acute Pancreatitis: An Evidence-Based Classification

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss changes Review the American College of Gastroenterology guidelines for the management of acute pancreatitis.
2. Discuss changes in treatment of acute pancreatitis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-175-H01-P
Initial release date: 05/20/2024
Expiration date: 05/20/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Traumatic patient interactions may not occur very often, depending on where you practice, but they are important teaching opportunities on many levels. It’s not just how you navigate trauma with a pharmacy learner that matters, but how you support them in processing what has occurred.

In this episode, we bring together a preceptor and her former resident for an impactful conversation on how to best assess, navigate, and process traumatic patient interactions with pharmacy residents or student pharmacists, and how those learnings transfer to other areas of pharmacy practice after the fact.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guests
Samantha Katzman, PharmD, BCEMP
Clinical Pharmacy Specialist – Emergency Medicine
University of Louisville Health – Jewish Hospital
Louisville, KY

McKenzie Packard, PharmD, BCPPS
Pediatric Clinical Pharmacist
Atrium Health Wake Forest Baptist
Winston-Salem, NC

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information

Learning Objectives
At the end of this course, preceptors will be able to:
1. Discuss strategies to assess pharmacy resident or student pharmacist readiness for a potentially traumatic patient interaction
2. Describe strategies preceptors can use to support pharmacy learners after a traumatic patient interaction

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-177-H99-P
Initial release date: 5/15/2024
Expiration date: 5/15/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Follow CEimpact on Social Media:
LinkedIn
Instagram